| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |